Why is Britain Losing its Chance to Become a Lifesciences Superpower?
In 2021, the United States-based company Grail recruited 140,000 individuals in England to test a blood test designed to identify cancer sooner and at a lower cost. This event provided us with another look into a potential future. If any or both of these clinical tests are successful, it has the potential to completely alter the landscape of how cancer is identified and treated. This would improve the overall quality of life for millions of people and could save the NHS billions of dollars, further establishing the United Kingdom as a Lifesciences Superpower. Here is why Britain Losing its Chance to Become a Lifesciences Superpower The United Kingdom’s Lifesciences Superpower potential is well-equipped to become a dominant force in the field of life sciences in the 21st century. However, demands in the near term are drowning out solutions in the long term, which is a waste of this significant potential. The revelation that the government is teaming with BioNTech to evaluate bre...